Current progress in the study on biosynthesis and regulation of ganoderic acids

Area of Science:

• Pharmacology
• Biochemistry
• Medicinal Chemistry

Background:

• Ganoderic acids (GAs) from Ganoderma lucidum possess significant pharmacological activities and therapeutic potential for various human diseases.
• Limited yield of GAs in cultivation hinders their development into new medicines, primarily due to insufficient knowledge of their biosynthesis pathway and regulation.

Purpose of the Study:

• To review recent publications on the biosynthesis and regulation of Ganoderic acids (GAs).
• To identify key genes and pathways involved in GA biosynthesis.
• To explore the influence of environmental factors on GA production.

Main Methods:

• Literature review of recent publications on GA biosynthesis and regulation.
• Identification and characterization of genes involved in the mevalonate pathway for GA synthesis.
• Transcriptional profiling analysis to correlate gene expression with environmental factors.

Main Results:

• Partial identification of the Ganoderic acid (GA) biosynthesis pathway, including the mevalonate pathway.
• Cloning and characterization of genes essential for GA biosynthesis.
• Demonstration of a close relationship between GA biosynthesis gene expression and environmental factor impacts via transcriptional profiling.

Conclusions:

• Understanding GA biosynthesis and regulation is crucial for improving yields and developing new medicines.
• Further research into the identified genes and regulatory mechanisms can optimize GAs production.
• This review provides insights and suggests future research directions for Ganoderic acid studies.